Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture
1015 15th Street, N.W., 6th Floor
Washington, DC 20005
On April 8, 2013, Hudson Institute’s Initiative on Future Innovation convened a distinguished panel of experts from business, science, public health, law, and the academic world for an off-the-record workshop on a working draft of Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture by Scott Gottlieb and Tevi Troy Dr. Gottlieb is a physician and resident fellow at the American Enterprise Institute, and formerly served as deputy commissioner of the Food and Drug Administration. Mr. Troy is a visiting fellow at Hudson Institute and former deputy secretary of the U.S. Department of Health and Human Services. Reclaiming Innovation in the Life Sciences — which will be published in final form as the fourth in a series of major research papers by Hudson’s Innovation Initiative, and thereafter available for download on this page — is a careful analysis of procedural rules and regulatory guidelines governing FDA review of proposed new medical treatments and pharmaceutical products, and a prescription for major reform of that system in the interests of improved public health and economic efficiency.
Join Hudson as an expert panel discusses the current state of Taiwan’s energy transition and how the island’s energy mix might change in the next several years.
Join Hudson for a conversation with the new generation of North Korean refugees on the future of American and South Korean policy to address the North Korean human rights challenge.
Join Hudson Institute as expert panels take stock of the Falun Gong crackdown over the past quarter of a century.
